EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Antiplatelets for Cardiovascular Disease in Non-valvular AF with Rivaroxaban: A Subanalysis of the EXPAND Study

Koichi Kaikita, Shinichiro Uchiyama, Hirotsugu Atarashi, Hiroshi Inoue, Takanari Kitazono, Takeshi Yamashita, Wataru Shimizu, Takanori Ikeda, Masahiro Kamouchi, Koji Fukuda, Hideki Origasa, Hiroaki Shimokawa

Journal of Atherosclerosis and Thrombosis · 2025

DOI: 10.5551/jat.64681 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2025. Verfasst von Koichi Kaikita und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki. Hauptthemen laut MEDLINE: Rivaroxaban, Atrial Fibrillation, Platelet Aggregation Inhibitors, Factor Xa Inhibitors. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RivaroxabanAtrial FibrillationPlatelet Aggregation InhibitorsFactor Xa InhibitorsCardiovascular DiseasesHumansFemaleMaleAgedMiddle AgedCoronary Artery DiseaseFollow-Up StudiesIschemic StrokePeripheral Arterial DiseaseHemorrhageDrug Therapy, Combination

Stichwörter der Autor:innen

Antiplatelet therapyBleedingNon-valvular atrial fibrillationRivaroxabanStroke

Substanzen

RivaroxabanPlatelet Aggregation InhibitorsFactor Xa Inhibitors

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki.
  • Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University.
  • Clinical Research Center for Medicine, Center for Brain and Cerebral Vessels, Sanno Medical Center.
  • Nippon Medical School.
  • Tama Nagayama Hospital.
  • Saiseikai Toyama Hospital.

Zitieren

APA

Kaikita, K., Uchiyama, S., Atarashi, H., Inoue, H., Kitazono, T., Yamashita, T., Shimizu, W., Ikeda, T., Kamouchi, M., Fukuda, K., Origasa, H., & Shimokawa, H. (2025). Antiplatelets for Cardiovascular Disease in Non-valvular AF with Rivaroxaban: A Subanalysis of the EXPAND Study. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.64681

Vancouver

Kaikita K, Uchiyama S, Atarashi H, Inoue H, Kitazono T, Yamashita T, et al. Antiplatelets for Cardiovascular Disease in Non-valvular AF with Rivaroxaban: A Subanalysis of the EXPAND Study. Journal of Atherosclerosis and Thrombosis. 2025. doi:10.5551/jat.64681

BibTeX
@article{Kaikita2025,
  author = {Kaikita, Koichi and Uchiyama, Shinichiro and Atarashi, Hirotsugu and Inoue, Hiroshi and Kitazono, Takanari and Yamashita, Takeshi and Shimizu, Wataru and Ikeda, Takanori and Kamouchi, Masahiro and Fukuda, Koji and Origasa, Hideki and Shimokawa, Hiroaki},
  title = {Antiplatelets for Cardiovascular Disease in Non-valvular AF with Rivaroxaban: A Subanalysis of the EXPAND Study},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2025},
  doi = {10.5551/jat.64681}
}
Kostenlos starten →